Genexine to Raise KRW 3 Billion in Private Placement

Genexine will raise KRW 3 billion through a private placement of 1,250,500 common shares to Korea Quantum AI. The issue price of KRW 2,399 per share represents a 10% discount to the reference price. Proceeds will fund working capital. * Payment is due Oct. 26, 2026; the new shares are scheduled to list Nov. 10, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genexine Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016000373), on October 16, 2026, and is solely responsible for the information contained therein. (C)